New indication approved for Pulmotil AC

Pulmotil AC gains indication for swine respiratory disease associated with Mycoplasma hyopneumoniae.

Elanco Animal Health announced the approval of Pulmotil AC (tilmicosin phosphate), an aqueous formulation for controlling swine respiratory disease associated with Mycoplasma hyopneumoniae in the presence of porcine reproductive and respiratory syndrome virus in groups of swine in buildings where a respiratory disease outbreak has been diagnosed.

Swine veterinarians can begin prescribing Pulmotil AC for this new indication immediately, Elanco said.

Pulmotil AC is also approved for control of swine respiratory disease in the presence of Pasteurella multocida and Haemophilus parasuis in groups of swine in buildings where a respiratory disease outbreak has been diagnosed.

As a liquid concentrate, Pulmotil AC works fast, the company said. There’s no need to formulate new rations or wait for bins to empty. Nor is flushing or sequencing required. It is cost-effective as well, eliminating labor costs associated with injectable treatments.

“The effectiveness of Pulmotil AC is well-established,” said Dr. Tom Marsteller, director of technical services for Elanco. “This liquid option for groups of swine in buildings where a respiratory disease outbreak has been diagnosed should prove advantageous because it gets the medication to the right pigs at the right time, and it provides flexibility to veterinarians and clients."

Pulmotil AC is an aqueous concentrate for oral use in drinking water for swine only. Always read, understand and follow product labels, inserts and warnings.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish